Clinical Trial Update: Oral Triiodothyronine for Infants Less Than 5 Months & Malnourished Children Undergoing Cardiopulmonary Bypass in Indonesia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oral triiodothyronine in infants under 5 months and malnourished children undergoing cardiopulmonary bypass has completed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Oral triiodothyronine (triiodothyronine)

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Postoperative; Dysfunction Following Cardiac Surgery | Phase 3 | Status: COMPLETED